305 related articles for article (PubMed ID: 29623443)
1. Pharmacokinetic and Pharmacodynamic Considerations of Antibiotics of Last Resort in Treating Gram-Negative Infections in Adult Critically Ill Patients.
Heavner MS; Claeys KC; Masich AM; Gonzales JP
Curr Infect Dis Rep; 2018 Apr; 20(5):10. PubMed ID: 29623443
[TBL] [Abstract][Full Text] [Related]
2. Optimal aminoglycoside therapy following the sepsis: how much is too much?
Mahmoudi L; Niknam R; Mousavi S; Ahmadi A; Honarmand H; Ziaie S; Mojtahedzadeh M
Iran J Pharm Res; 2013; 12(2):261-9. PubMed ID: 24250599
[TBL] [Abstract][Full Text] [Related]
3. What is the relevance of fosfomycin pharmacokinetics in the treatment of serious infections in critically ill patients? A systematic review.
Parker S; Lipman J; Koulenti D; Dimopoulos G; Roberts JA
Int J Antimicrob Agents; 2013 Oct; 42(4):289-93. PubMed ID: 23880170
[TBL] [Abstract][Full Text] [Related]
4. Reappraisal of Contemporary Pharmacokinetic and Pharmacodynamic Principles for Informing Aminoglycoside Dosing.
Bland CM; Pai MP; Lodise TP
Pharmacotherapy; 2018 Dec; 38(12):1229-1238. PubMed ID: 30403305
[TBL] [Abstract][Full Text] [Related]
5. Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii.
Luque S; Grau S; Valle M; Sorlí L; Horcajada JP; Segura C; Alvarez-Lerma F
Int J Antimicrob Agents; 2013 Aug; 42(2):178-81. PubMed ID: 23769664
[TBL] [Abstract][Full Text] [Related]
6. Optimizing use of colistin and polymyxin B in the critically ill.
Nation RL; Li J
Semin Respir Crit Care Med; 2007 Dec; 28(6):604-14. PubMed ID: 18095224
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic issues for antibiotics in the critically ill patient.
Roberts JA; Lipman J
Crit Care Med; 2009 Mar; 37(3):840-51; quiz 859. PubMed ID: 19237886
[TBL] [Abstract][Full Text] [Related]
8. Population Pharmacokinetics of High-Dose Tigecycline in Patients with Sepsis or Septic Shock.
Borsuk-De Moor A; Rypulak E; Potręć B; Piwowarczyk P; Borys M; Sysiak J; Onichimowski D; Raszewski G; Czuczwar M; Wiczling P
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358291
[TBL] [Abstract][Full Text] [Related]
9. Beta-Lactams Dosing in Critically Ill Patients with Gram-Negative Bacterial Infections: A PK/PD Approach.
Maguigan KL; Al-Shaer MH; Peloquin CA
Antibiotics (Basel); 2021 Sep; 10(10):. PubMed ID: 34680734
[TBL] [Abstract][Full Text] [Related]
10. Optimisation of antimicrobial dosing based on pharmacokinetic and pharmacodynamic principles.
Hoo GSR; Liew YX; Kwa AL
Indian J Med Microbiol; 2017; 35(3):340-346. PubMed ID: 29063877
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock.
Varghese JM; Roberts JA; Lipman J
Crit Care Clin; 2011 Jan; 27(1):19-34. PubMed ID: 21144984
[TBL] [Abstract][Full Text] [Related]
12. Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of Aerosolized Colistin in a Mouse Lung Infection Model.
Lin YW; Zhou QT; Han ML; Onufrak NJ; Chen K; Wang J; Forrest A; Chan HK; Li J
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263069
[TBL] [Abstract][Full Text] [Related]
13. Optimization of Therapy and the Risk of Probiotic Use during Antibiotherapy in Septic Critically Ill Patients: A Narrative Review.
Onofrei MI; Ghiciuc CM; Luca CM; Postolache P; Sapaniuc C; Enache Leonte G; Rosu FM
Medicina (Kaunas); 2023 Feb; 59(3):. PubMed ID: 36984479
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic drug monitoring of carbapenem antibiotics in critically ill patients: an overview of principles, recommended dosing regimens, and clinical outcomes.
Joynt GM; Ling L; Wong WT; Lipman J
Expert Rev Clin Pharmacol; 2023; 16(8):703-714. PubMed ID: 36942827
[TBL] [Abstract][Full Text] [Related]
15. Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development.
Abdul-Aziz MH; Lipman J; Mouton JW; Hope WW; Roberts JA
Semin Respir Crit Care Med; 2015 Feb; 36(1):136-53. PubMed ID: 25643277
[TBL] [Abstract][Full Text] [Related]
16. A Systematic Review of Studies Reporting Antibiotic Pharmacokinetic Data in the Cerebrospinal Fluid of Critically Ill Patients with Uninflamed Meninges.
Kumta N; Roberts JA; Lipman J; Wong WT; Joynt GM; Cotta MO
Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33077649
[TBL] [Abstract][Full Text] [Related]
17. How to optimize antibiotic pharmacokinetic/pharmacodynamics for Gram-negative infections in critically ill patients.
Heffernan AJ; Sime FB; Taccone FS; Roberts JA
Curr Opin Infect Dis; 2018 Dec; 31(6):555-565. PubMed ID: 30299354
[TBL] [Abstract][Full Text] [Related]
18. The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections.
Tängdén T; Ramos Martín V; Felton TW; Nielsen EI; Marchand S; Brüggemann RJ; Bulitta JB; Bassetti M; Theuretzbacher U; Tsuji BT; Wareham DW; Friberg LE; De Waele JJ; Tam VH; Roberts JA;
Intensive Care Med; 2017 Jul; 43(7):1021-1032. PubMed ID: 28409203
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacokinetic/pharmacodynamic profile of linezolid in severely ill intensive care unit patients.
Dong H; Wang X; Dong Y; Lei J; Li H; You H; Wang M; Xing J; Sun J; Zhu H
Int J Antimicrob Agents; 2011 Oct; 38(4):296-300. PubMed ID: 21741222
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a retrospective analysis of four years of clinical experience.
Richter DC; Frey O; Röhr A; Roberts JA; Köberer A; Fuchs T; Papadimas N; Heinzel-Gutenbrunner M; Brenner T; Lichtenstern C; Weigand MA; Brinkmann A
Infection; 2019 Dec; 47(6):1001-1011. PubMed ID: 31473974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
